DNA 읽기, 쓰기, 편집 시장

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

The North American market for DNA read, write, and edit was valued at $11.2 billion in 2025 and is estimated to reach $28.1 billion by 2030, at a CAGR of 20.2% from 2025 through 2030.

The Asia-Pacific market for DNA read, write, and edit was valued at $6 billion in 2025 and is estimated to reach $17.2 billion by 2030, at a CAGR of 23.4% from 2025 through 2030.

Report Scope

The scope of the global DNA read, write, and edit market study encompasses market size analysis, as well as a detailed examination of the competitive environment, market dynamics, ongoing research, and driving trends driving market growth. The market has been segmented based on technology, application, and region.

The report provides an overview of the global DNA read, write, and edit market, analyzing market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

The report covers the total market for DNA read, write, and edit, which includes DNA sequencing, DNA writing, and gene editing. Applications for these products in clinical, research, and other applied areas are also included in the report. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, the Asia-Pacific, and the Rest of the World, with a focus on major countries in these regions.

The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and emerging technologies related to the market. It also covers a section on the regulatory landscape of the industry.

The report concludes with an analysis of the competitive landscape and industry structure. It also has a dedicated section of company profiles that covers details of leading companies in the market.

Report Includes

• 89 data tables and 59 additional tables
• An overview of the global market for DNA read, write and edit technologies
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to DNA read, write and edit technologies, accompanied by a market share analysis by technology, application, and region
• Analysis of current and future demand in the global DNA read, write and edit technologies, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges, and opportunities affecting market growth
• Information on sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
• A look at the evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, and ESG trends of the market
• Market share analysis of the key market participants, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Oxford Nanopore Technologies plc., and BGI

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Sequencing Technologies
• Sanger Sequencing
• Third-Generation Sequencing
• Gene Synthesis Processes
• Solid Phase Chemical Synthesis
• Genome Editing Technologies
• Meganucleases
• Zinc Finger Nucleases (ZFNs)
• Transcription Activator-like Effector Nucleases (TALENs)
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated Protein 9 (Cas9)
• Porter's Five Forces Analysis in the DNA Read, Write, and Edit Market
• Macroeconomic Factor Analysis
• U.S. Tariffs
• Geopolitical Factors
• Increasing Healthcare Expenditures

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Growing Need for Early Detection of Chronic Diseases
• Increasing Prevalence of Infectious Diseases
• Growing Private Funding for Genome Editing
• Market Restraints
• Complex and Evolving Regulatory Landscape
• High Costs of Sequencing Instruments
• Off-Target Impacts of CRISPR Technology
• Market Opportunities
• Expanding Clinical Applications of Genome Editing
• Applications in Plant and Livestock Breeding
• Development of Next-Generation CAR-T Therapies

Chapter 4 Regulatory Landscape

• Regulatory Paths for Genome Editing
• North America
• Europe (EU)
• Asia-Pacific
• Regulatory Landscape Across the Rest of the World

Chapter 5 Emerging Technologies

• Key Takeaways
• Emerging Technologies
• Advances in Sequencing Technologies
• In Vivo Delivery of CRISPR
• CRISPR-Based Diagnostics
• Artificial Intelligence (AI) in DNA Data Analysis

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Technology
• Key Takeaways
• DNA Read (Sequencing)
• DNA Write (Synthesis)
• DNA Edit (Genome Editing)
• Market Analysis by Application
• Key Takeaways
• Clinical Applications
• Research
• Applied
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Industry Structure
• Competitive Analysis of the DNA Read Market
• Strategic Analysis
• Funding Outlook

Chapter 8 Sustainability in the DNA Read, Write, and Edit Market: An ESG Perspective

• Introduction to ESG
• ESG Practices in the DNA Read, Write, and Edit Industry
• Environmental Performance
• ESG Risk Ratings
• Conclusion

Chapter 9 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BEAM THERAPEUTICS
• CHARLES RIVER LABORATORIES
• EUROFINS GENOMICS
• F. HOFFMANN-LA ROCHE LTD.
• GENSCRIPT
• ILLUMINA INC.
• INTEGRATED DNA TECHNOLOGIES INC.
• MERCK KGAA
• OXFORD NANOPORE TECHNOLOGIES PLC.
• PACBIO
• QIAGEN
• REVVITY
• THERMO FISHER SCIENTIFIC INC.
• VERTEX PHARMACEUTICALS INC.
• Emerging Startups/ Market Disruptors